Yubo International Biotech Ltd (YBGJ) stock
YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.01+0.00 (0.00%)
Close on Oct 16, 2026Market cap $886.19KP/E –Yield –
Yubo International Biotech operating margin
Operating margin is operating income as a percentage of revenue.
Yubo International Biotech's operating margin for the twelve months ending Jun 30, 2026 was -9096.9%. For fiscal 2026 it was -9614.6%, against -51006.3% the year before. The highest annual figure on record is -124.0% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Dec 31, 2025 | -9614.6% | +41391.7 |
| FY2025 | Dec 31, 2024 | -51006.3% | −50808.7 |
| FY2024 | Dec 31, 2023 | -197.6% | +958.1 |
| FY2023 | Dec 31, 2022 | -1155.7% | −1031.7 |
| FY2022 | Dec 31, 2021 | -124.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026CQ4 2025 | Dec 31, 2025 | -2310.9% | +23372.7 |
| Q1 FY2025CQ1 2024 | Mar 31, 2024 | -11738.0% | −11535.9 |
| Q4 FY2024CQ4 2023 | Dec 31, 2023 | -2321.3% | −2476.8 |
| Q3 FY2024CQ3 2023 | Sep 30, 2023 | 1.5% | +1635.7 |
| Q2 FY2024CQ2 2023 | Jun 30, 2023 | -25683.6% | −19516.8 |
| Q1 FY2024CQ1 2023 | Mar 31, 2023 | -202.1% | +3603.4 |
| Q4 FY2023CQ4 2022 | Dec 31, 2022 | 155.6% | +272.4 |
| Q3 FY2023CQ3 2022 | Sep 30, 2022 | -1634.2% | −1282.2 |
| Q2 FY2023CQ2 2022 | Jun 30, 2022 | -6166.9% | – |
| Q1 FY2023CQ1 2022 | Mar 31, 2022 | -3805.5% | – |
| Q4 FY2022CQ4 2021 | Dec 31, 2021 | -116.8% | – |
| Q3 FY2022CQ3 2021 | Sep 30, 2021 | -352.0% | – |
See a number that looks wrong?